The gastrin receptor antagonist netazepide (YF476) in patients with type 1 gastric enterochromaffin-like cell neuroendocrine tumours: review of long-term treatment.
作者： Liv Sagatun , Patricia Mjønes , Constantin S. Jianu , Malcolm Boyce , Hege L. Waldum
DOI: 10.1097/MEG.0000000000000713
关键词:
摘要: ObjectiveNetazepide (YF476) is a recently developed, orally active gastrin receptor antagonist that, in short trials patients with type 1 gastric enterochromaffin-like cell neuroendocrine tumours, has been shown to induce significant reduction the number and size of tumours as well serum
sci-hub.se 参考文章(57)
Raper Se, Eckhauser Fe, Vinik Ai, Thompson Nw, Lloyd Rv, Antrectomy for multicentric, argyrophil gastric carcinoids: a preliminary report. Surgery. ,vol. 104, pp. 1046- 1053 ,(1988)
Gwen Murphy, Sanford M. Dawsey, Eric A. Engels, Winnie Ricker, Ruth Parsons, Arash Etemadi, Shih-Wen Lin, Christian C. Abnet, Neal D. Freedman, Cancer Risk After Pernicious Anemia in the US Elderly Population Clinical Gastroenterology and Hepatology. ,vol. 13, pp. 2282- 2289.e4 ,(2015) , 10.1016/J.CGH.2015.05.040
Simona Grozinsky-Glasberg, Metastatic type 1 gastric carcinoid: A real threat or just a myth? World Journal of Gastroenterology. ,vol. 19, pp. 8687- 8695 ,(2013) , 10.3748/WJG.V19.I46.8687
Malcolm Boyce, Sally Dowen, Gillian Turnbull, Frans van den Berg, Chun-Mei Zhao, Duan Chen, James Black, Effect of netazepide, a gastrin/CCK2 receptor antagonist, on gastric acid secretion and rabeprazole-induced hypergastrinaemia in healthy subjects. British Journal of Clinical Pharmacology. ,vol. 79, pp. 744- 755 ,(2015) , 10.1111/BCP.12534
Ewald R. Weibel, Stereological Principles for Morphometry in Electron Microscopic Cytology International Review of Cytology. ,vol. 26, pp. 235- 302 ,(1969) , 10.1016/S0074-7696(08)61637-X
L. Vannella, A. Sbrozzi-Vanni, E. Lahner, C. Bordi, E. Pilozzi, V. D. Corleto, J. F. Osborn, G. Delle Fave, B. Annibale, Development of Type I Gastric Carcinoid in patients with Chronic atrophic gastritis Alimentary Pharmacology & Therapeutics. ,vol. 33, pp. 1361- 1369 ,(2011) , 10.1111/J.1365-2036.2011.04659.X
Malcolm Boyce, Steve Warrington, James Black, Netazepide, a gastrin/CCK2 receptor antagonist, causes dose‐dependent, persistent inhibition of the responses to pentagastrin in healthy subjects British Journal of Clinical Pharmacology. ,vol. 76, pp. 689- 698 ,(2013) , 10.1111/BCP.12099
Kurt Borch, Henrik Renvall, Gustav Liedberg, Gastric endocrine cell hyperplasia and carcinoid tumors in pernicious anemia Gastroenterology. ,vol. 88, pp. 638- 648 ,(1985) , 10.1016/0016-5085(85)90131-3
Bruno Annibale, Cinzia Azzoni, Vito D. Corleto, Emilio di Giulio, Pietro Caruana, Giancarlo D'Ambra, Cesare Bordi, Gianfranco Delle Fave, Atrophic body gastritis patients with enterochromaffin-like cell dysplasia are at increased risk for the development of type I gastric carcinoid. European Journal of Gastroenterology & Hepatology. ,vol. 13, pp. 1449- 1456 ,(2001) , 10.1097/00042737-200112000-00008
P. M. Kleveland, S. E. Haugen, H. L. Waldum, The preparation of bioactive 125I-gastrin, using Iodo-gen as oxidizing agent, and the use of this tracer in receptor studies. Scandinavian Journal of Gastroenterology. ,vol. 20, pp. 569- 576 ,(1985) , 10.3109/00365528509089698